Slabospitskaia A T, Vinogradov V P, Krymovskaia S S, Reznik S R, Smirnov V V
Mikrobiol Z. 1995 Jan-Feb;57(1):71-6.
Biosporin, a new biological drug made on the basis of sporulating aerobic bacteria, has been studied for its effect on the intestine microflora in case of dysbacterioses and acute digestive disorders in 53 newborn children with perinatal pathology. The results obtained prove high prophylactic and therapeutic efficiency (clinical and bacteriological) of biosporin for dysbacterioses and diarrheas in the newborn children. No negative after effects were observed. The preparation not only decontaminated pathogenic microorganisms, but also promoted necessary correction bacteriotherapy.
生物孢菌素是一种基于产孢需氧菌制成的新型生物药物，针对53例患有围产期病理的新生儿的菌群失调和急性消化紊乱情况，研究了其对肠道微生物群的影响。所获结果证明生物孢菌素对新生儿菌群失调和腹泻具有很高的预防和治疗效果（临床和细菌学方面）。未观察到负面后遗症。该制剂不仅能清除致病微生物，还能促进必要的纠正性细菌疗法。
